Management of unilateral neck irradiation in elderly patients with head and neck cancer: Which place for hypofractionation? A single-centre experience of 43 patients.

Manou Rakotosamimanana, Sophie Renard-Oldrini, Nassim Sahki, Jean-Christophe Faivre
{"title":"Management of unilateral neck irradiation in elderly patients with head and neck cancer: Which place for hypofractionation? A single-centre experience of 43 patients.","authors":"Manou Rakotosamimanana, Sophie Renard-Oldrini, Nassim Sahki, Jean-Christophe Faivre","doi":"10.1016/j.canrad.2024.07.018","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of the study: </strong>The purpose of the study was to evaluate retrospectively the acute toxicity and efficacy in terms of locoregional control of a cervical lymph node irradiation using a hypofractionated regimen in frail elderly patients.</p><p><strong>Material and methods: </strong>Patients receiving unilateral hypofractionated cervical lymph node irradiation at the Institut de cancérologie de Lorraine (France) were retrospectively included. The treatment regimen consisted of delivering 54Gy in 18 fractions to the high-risk tumour or lymph node volume and 45Gy to the prophylactic volume using the technique of simultaneous integrated-boost without concomitant systemic treatment. Toxicity data according to the Common Terminology Criteria for Adverse Events version 4 and survival data were collected.</p><p><strong>Results: </strong>Forty-three patients were treated between January 2013 and July 2021. The median age was 83 years (range: 78-86.5 years), 32 patients (74.4 %) were male and 25.6 % had WHO status ≥ 2. Histological types were cutaneous squamous cell carcinoma (39 patients), salivary gland carcinoma (three patients) and Merkel cell carcinoma (one patient). The mean duration of treatment was 27 days. Seventeen patients (39.5 %) received radiotherapy alone. Acute toxicity events of grade ≥ 2 at the end of radiotherapy in the 43 patients were described as follows: 58.1 % radiodermatitis (25 patients), 24.6 % mucositis (11 patients), and 18.1 % xerostomia (eight patients). Seven patients (16.3 %) experienced grade ≥ 2 odynodysphagia, with four patients (9.3 %) requiring enteral nutrition. No grade 3 toxicity events were reported at 3 months, 6 months or 1 year. After a median follow-up of 9.2 months (range: 6-18.5 months), 11 patients (25.6 %) of those treated by exclusive irradiation had a complete locoregional response as assessed by CT-scan 3 months. At 6 months, two of 20 patients retained grade 2 xerostomia and only four of 20 patients reported residual grade 1 pain.</p><p><strong>Conclusion: </strong>Moderately hypofractionated unilateral cervical lymph node radiotherapy appears to be well tolerated in frail elderly patients with an acceptable locoregional control rate, potentially providing an alternative to palliative strategies.</p>","PeriodicalId":93921,"journal":{"name":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.canrad.2024.07.018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of the study: The purpose of the study was to evaluate retrospectively the acute toxicity and efficacy in terms of locoregional control of a cervical lymph node irradiation using a hypofractionated regimen in frail elderly patients.

Material and methods: Patients receiving unilateral hypofractionated cervical lymph node irradiation at the Institut de cancérologie de Lorraine (France) were retrospectively included. The treatment regimen consisted of delivering 54Gy in 18 fractions to the high-risk tumour or lymph node volume and 45Gy to the prophylactic volume using the technique of simultaneous integrated-boost without concomitant systemic treatment. Toxicity data according to the Common Terminology Criteria for Adverse Events version 4 and survival data were collected.

Results: Forty-three patients were treated between January 2013 and July 2021. The median age was 83 years (range: 78-86.5 years), 32 patients (74.4 %) were male and 25.6 % had WHO status ≥ 2. Histological types were cutaneous squamous cell carcinoma (39 patients), salivary gland carcinoma (three patients) and Merkel cell carcinoma (one patient). The mean duration of treatment was 27 days. Seventeen patients (39.5 %) received radiotherapy alone. Acute toxicity events of grade ≥ 2 at the end of radiotherapy in the 43 patients were described as follows: 58.1 % radiodermatitis (25 patients), 24.6 % mucositis (11 patients), and 18.1 % xerostomia (eight patients). Seven patients (16.3 %) experienced grade ≥ 2 odynodysphagia, with four patients (9.3 %) requiring enteral nutrition. No grade 3 toxicity events were reported at 3 months, 6 months or 1 year. After a median follow-up of 9.2 months (range: 6-18.5 months), 11 patients (25.6 %) of those treated by exclusive irradiation had a complete locoregional response as assessed by CT-scan 3 months. At 6 months, two of 20 patients retained grade 2 xerostomia and only four of 20 patients reported residual grade 1 pain.

Conclusion: Moderately hypofractionated unilateral cervical lymph node radiotherapy appears to be well tolerated in frail elderly patients with an acceptable locoregional control rate, potentially providing an alternative to palliative strategies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
老年头颈癌患者单侧颈部照射的管理:在哪个部位进行低分量照射?43例患者的单中心经验。
研究目的该研究旨在回顾性评估体弱老年患者采用低分量方案进行宫颈淋巴结照射的急性毒性和局部控制疗效:回顾性纳入在法国洛林癌症研究所(Institut de cancérologie de Lorraine)接受单侧低剂量宫颈淋巴结照射的患者。治疗方案包括在不同时进行全身治疗的情况下,采用同步综合增强技术,对高危肿瘤或淋巴结体积分18次照射54Gy,对预防性体积照射45Gy。根据《不良事件通用术语标准》第4版收集了毒性数据和生存数据:43名患者在2013年1月至2021年7月期间接受了治疗。中位年龄为 83 岁(78-86.5 岁),32 名患者(74.4%)为男性,25.6% 的患者 WHO 状态≥ 2。组织学类型为皮肤鳞状细胞癌(39 名患者)、唾液腺癌(3 名患者)和梅克尔细胞癌(1 名患者)。平均治疗时间为 27 天。17名患者(39.5%)只接受了放射治疗。43名患者在放疗结束时出现的急性毒性反应≥2级的情况如下:放射皮炎(25 例)占 58.1%,粘膜炎(11 例)占 24.6%,口腔溃疡(8 例)占 18.1%。7名患者(16.3%)出现≥2级吞咽困难,其中4名患者(9.3%)需要肠内营养。在 3 个月、6 个月或 1 年的随访中,均未报告 3 级毒性事件。中位随访 9.2 个月(范围:6-18.5 个月)后,经 CT 扫描评估,在接受独家照射治疗的患者中,有 11 名患者(25.6%)在 3 个月后获得了完全的局部反应。6个月后,20名患者中有2人仍有2级口腔异物感,20名患者中仅有4人报告有1级疼痛残留:中度低分次单侧颈淋巴结放疗对体弱老年患者的耐受性良好,局部控制率可接受,有可能成为姑息治疗策略的替代方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Is hypofractionated radiotherapy used to treat soft tissue sarcomas? Assessment of practices using the NETSARC network. Management of unilateral neck irradiation in elderly patients with head and neck cancer: Which place for hypofractionation? A single-centre experience of 43 patients. Oncological outcomes of patients with muscle-invasive bladder cancer treated with trimodal strategy: A French multicentric study. Permanent alopecia after radiotherapy of primary brain tumours: The most influential factors. Safety of concurrent trastuzumab-emtansine and radiation therapy for breast cancer: Single-centre experience from a morbidity and mortality review meetings procedure.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1